StockData
Herbalife Ltd. logo

Herbalife Ltd. (HLF) stock

HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 9/3042% below fair value
$16.04+0.47 (+3.02%)

Close on Nov 18, 2026Market cap $1.68BP/E 10.3Yield –

Herbalife operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Herbalife's operating cash flow for the twelve months ending Jun 30, 2026 was $383.80M, up 44.7% year over year. For fiscal 2025 it was $333.30M, up 16.8% from the year before. Over ten years it grew -6.1% a year on average. The highest annual figure on record is $772.90M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$333.30M+16.8%
FY2024Dec 31, 2024$285.40M-20.2%
FY2023Dec 31, 2023$357.50M+1.4%
FY2022Dec 31, 2022$352.50M-23.4%
FY2021Dec 31, 2021$460.30M-26.8%
FY2020Dec 31, 2020$628.60M+37.4%
FY2019Dec 31, 2019$457.50M-29.4%
FY2018Dec 31, 2018$648.40M+9.7%
FY2017Dec 31, 2017$590.80M+60.8%
FY2016Dec 31, 2016$367.30M-41.6%
FY2015Dec 31, 2015$628.70M+22.9%
FY2014Dec 31, 2014$511.40M-33.8%
FY2013Dec 31, 2013$772.90M+36.1%
FY2012Dec 31, 2012$567.80M+11.2%
FY2011Dec 31, 2011$510.54M+31.6%
FY2010Dec 31, 2010$387.88M+36.1%
FY2009Dec 31, 2009$285.06M+4.4%
FY2008Dec 31, 2008$272.99M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$32.90M-65.7%
Q1 FY2026Mar 31, 2026$113.80M+56800.0%
Q4 FY2025Dec 31, 2025$98.30M+41.2%
Q3 FY2025Sep 30, 2025$138.80M+39.5%
Q2 FY2025Jun 30, 2025$96.00M-6.3%
Q1 FY2025Mar 31, 2025$200.00K-98.6%
Q4 FY2024Dec 31, 2024$69.60M-27.6%
Q3 FY2024Sep 30, 2024$99.50M+25.0%
Q2 FY2024Jun 30, 2024$102.50M-24.4%
Q1 FY2024Mar 31, 2024$13.80M-70.1%
Q4 FY2023Dec 31, 2023$96.10M+79.3%
Q3 FY2023Sep 30, 2023$79.60M+14.4%
Q2 FY2023Jun 30, 2023$135.60M+37.2%
Q1 FY2023Mar 31, 2023$46.20M-64.6%
Q4 FY2022Dec 31, 2022$53.60M-37.2%
Q3 FY2022Sep 30, 2022$69.60M-20.9%
Q2 FY2022Jun 30, 2022$98.80M-44.1%
Q1 FY2022Mar 31, 2022$130.50M+18.5%
Q4 FY2021Dec 31, 2021$85.40M-24.1%
Q3 FY2021Sep 30, 2021$88.00M-32.9%
Q2 FY2021Jun 30, 2021$176.80M-27.3%
Q1 FY2021Mar 31, 2021$110.10M-22.3%
Q4 FY2020Dec 31, 2020$112.50M-28.2%
Q3 FY2020Sep 30, 2020$131.10M-29.6%
Q2 FY2020Jun 30, 2020$243.30M+218.9%
Q1 FY2020Mar 31, 2020$141.70M+268.1%
Q4 FY2019Dec 31, 2019$156.60M+12.9%
Q3 FY2019Sep 30, 2019$186.10M+12.9%
Q2 FY2019Jun 30, 2019$76.30M-59.6%
Q1 FY2019Mar 31, 2019$38.50M-75.4%
Q4 FY2018Dec 31, 2018$138.70M-25.6%
Q3 FY2018Sep 30, 2018$164.80M+29.5%
Q2 FY2018Jun 30, 2018$188.70M+85.7%
Q1 FY2018Mar 31, 2018$156.20M-11.0%
Q4 FY2017Dec 31, 2017$186.40M+58.8%
Q3 FY2017Sep 30, 2017$127.30M–
Q2 FY2017Jun 30, 2017$101.60M–
Q1 FY2017Mar 31, 2017$175.50M–
Q4 FY2016Dec 31, 2016$117.40M–
Q3 FY2016Sep 30, 2016-$118.10M–

More Herbalife figures

See a number that looks wrong?